Last updated on March 2019

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema


Brief description of study

The purpose of this study is to evaluate the efficacy and safety of brolucizumab in treatment of patients with visual impairment due to diabetic macular edema (DME).

Detailed Study Description

In this 2-year, randomized, double-masked, multicenter, active controlled study, consenting patients will be randomized in a 1:1:1 ratio to one of the three treatment arms (Brolucizumab 3 mg, Brolucizumab 6 mg, or Aflibercept 2 mg) and attend 28 planned visits.

Clinical Study Identifier: NCT03481634

Find a site near you

Start Over

Novartis Investigative Site

New Albany, IN United States
  Connect »

Novartis Investigative Site

Beverly Hills, CA United States
  Connect »

Novartis Investigative Site

Santa Barbara, CA United States
  Connect »

Novartis Investigative Site

Colorado Springs, CO United States
  Connect »

Novartis Investigative Site

Charlotte, NC United States
  Connect »

Novartis Investigative Site

Houston, TX United States
  Connect »

Novartis Investigative Site

Spokane, WA United States
  Connect »

Novartis Investigative Site

Danbury, CT United States
  Connect »

Novartis Investigative Site

Fort Myers, FL United States
  Connect »

Novartis Investigative Site

Leawood, KS United States
  Connect »

Novartis Investigative Site

Shawnee Mission, KS United States
  Connect »

Novartis Investigative Site

Paducah, KY United States
  Connect »

Novartis Investigative Site

Cincinnati, OH United States
  Connect »

Novartis Investigative Site

Cleveland, OH United States
  Connect »

Novartis Investigative Site

Kingston, PA United States
  Connect »

Novartis Investigative Site

Memphis, TN United States
  Connect »

Novartis Investigative Site

Harlingen, TX United States
  Connect »

Novartis Investigative Site

Madison, WI United States
  Connect »

Novartis Investigative Site

Stoneham, MA United States
  Connect »

Novartis Investigative Site

Nashville, TN United States
  Connect »

Novartis Investigative Site

Philadelphia, PA United States
  Connect »

Novartis Investigative Site

Wheaton, IL United States
  Connect »

Novartis Investigative Site

Indianapolis, IN United States
  Connect »

Novartis Investigative Site

Phoenix, AZ United States
  Connect »

Novartis Investigative Site

Silverdale, WA United States
  Connect »

Novartis Investigative Site

La Jolla, CA United States
  Connect »

Novartis Investigative Site

Santa Maria da Feira, Portugal
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.